These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23884182)

  • 1. Erythropoiesis-stimulating agents in heart failure: no proof of effectiveness or proof of no effectiveness?
    Messori A; Fadda V; Maratea D; Trippoli S
    Eur J Heart Fail; 2013 Aug; 15(8):944-5. PubMed ID: 23884182
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythropoietin and heart failure: the end of a promise?
    Kleijn L; Westenbrink BD; van der Meer P
    Eur J Heart Fail; 2013 May; 15(5):479-81. PubMed ID: 23558218
    [No Abstract]   [Full Text] [Related]  

  • 3. Haemodilution is a mechanism of anaemia in patients with heart failure: reply.
    Westenbrink BD; Kleijn L; van der Meer P
    Eur J Heart Fail; 2013 Sep; 15(9):1075-6. PubMed ID: 23960086
    [No Abstract]   [Full Text] [Related]  

  • 4. Haemodilution is a mechanism of anaemia in patients with heart failure.
    Prakash ES
    Eur J Heart Fail; 2013 Sep; 15(9):1074. PubMed ID: 23883650
    [No Abstract]   [Full Text] [Related]  

  • 5. Erythropoiesis-stimulating agents in kidney and cardiac disease.
    Fluck R
    Br J Hosp Med (Lond); 2006 Oct; 67(10):533-7. PubMed ID: 17069130
    [No Abstract]   [Full Text] [Related]  

  • 6. Darbapoetin alfa does not help adults with heart failure and anaemia.
    BMJ; 2013 Mar; 346():f1626. PubMed ID: 23487165
    [No Abstract]   [Full Text] [Related]  

  • 7. Correcting anemia in heart failure: the efficacy and safety of erythropoiesis-stimulating agents.
    Lawler PR; Filion KB; Eisenberg MJ
    J Card Fail; 2010 Aug; 16(8):649-58. PubMed ID: 20670844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anemia and heart failure: Is there still a role for erythropoiesis-stimulating agents?
    Volpe M; Mastromariona V
    Turk Kardiyol Dern Ars; 2017 Apr; 45(3):217-218. PubMed ID: 28429688
    [No Abstract]   [Full Text] [Related]  

  • 9. Erythropoiesis stimulating agents (ESAs) for congestive heart failure: the red and the black.
    Robles NR; Macias JF; Herrera J
    Eur J Intern Med; 2014 Feb; 25(2):193-6. PubMed ID: 24491240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The etiology of anemia in heart failure. Preface.
    Agarwal AK; Katz SD; Singh AK
    Heart Fail Clin; 2010 Jul; 6(3):xvii-xviii. PubMed ID: 20630400
    [No Abstract]   [Full Text] [Related]  

  • 11. Warning flags for erythropoiesis-stimulating agents and cancer-associated anemia.
    Lappin TR; Maxwell AP; Johnston PG
    Oncologist; 2007 Apr; 12(4):362-5. PubMed ID: 17470677
    [No Abstract]   [Full Text] [Related]  

  • 12. [Would prescription of erythropoiesis-stimulating agents in pre-dialysis change after results from TREAT study?].
    Alcázar R; Tato A; García F; Barrios V; Quereda C
    Nefrologia; 2010; 30(1):114-8. PubMed ID: 20038963
    [No Abstract]   [Full Text] [Related]  

  • 13. Summaries of nursing care-related systematic reviews from the Cochrane library: erythropoiesis-stimulating agents for anemia in chronic heart failure patients.
    Barrett D
    J Cardiovasc Nurs; 2010; 25(5):381-2. PubMed ID: 20714234
    [No Abstract]   [Full Text] [Related]  

  • 14. Erythropoiesis-stimulating agents in heart failure: leave it or re-take it?
    Volpe M; Santolamazza C; Mastromarino V
    Eur J Heart Fail; 2015 Nov; 17(11):1089-90. PubMed ID: 26531211
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current issues in erythropoietin therapy of renal anemia].
    Zakar G
    Lege Artis Med; 2007 Oct; 17(10):667-73. PubMed ID: 19227596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Erythropoiesis-stimulating agents in congestive heart failure patients].
    Robles Perez-Monteoliva NR; Macías Núñez JF; Herrera Pérez de Villar J
    Med Clin (Barc); 2014 Mar; 142(5):215-8. PubMed ID: 24012446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of erythropoietin in heart failure management.
    Caiola K; Cheng JW
    Ann Pharmacother; 2004 Dec; 38(12):2145-9. PubMed ID: 15494385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anemia in chronic heart failure.
    Drakos SG; Anastasiou-Nana MI; Malliaras KG; Nanas JN
    Congest Heart Fail; 2009; 15(2):87-92. PubMed ID: 19379455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoiesis-stimulating agents in the treatment of cancer-associated anemia.
    Bohlius J; Engert A; Schwarzer G
    JAMA; 2008 Dec; 300(24):2854-5; author reply 2855-7. PubMed ID: 19109112
    [No Abstract]   [Full Text] [Related]  

  • 20. Anemia associated with chronic heart failure: current concepts.
    Shah R; Agarwal AK
    Clin Interv Aging; 2013; 8():111-22. PubMed ID: 23403618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.